Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 16, 2021 - Issue
Submit an article Journal homepage
100
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England

Leah B Sansbury1 Value Evidence and Outcomes, GlaxoSmithKline, Research Triangle Park, Durham, NC, USAView further author information
,
Kieran J Rothnie2 Value and Evidence Outcomes, GlaxoSmithKline, Uxbridge, UKView further author information
,
Chanchal Bains3 Real World Evidence and Epidemiology, GlaxoSmithKline, Uxbridge, UKView further author information
,
Chris Compton4 Global Respiratory Franchise, GlaxoSmithKline, Brentford, UKView further author information
,
Glenn Anley2 Value and Evidence Outcomes, GlaxoSmithKline, Uxbridge, UKView further author information
&
Afisi S Ismaila5 Value Evidence and Outcomes, GlaxoSmithKline, Collegeville, PA, USA;6 Department of Health Research Methods, McMaster University, Hamilton, ON, CanadaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2876-8308View further author information
ORCID Icon
Pages 2591-2604 | Published online: 15 Sep 2021

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Kieran J Rothnie, Beade Numbere, Steven Gelwicks, Yifei Lu, Raj Sharma, Chris Compton, Afisi S Ismaila & Jennifer K Quint. (2023) Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2673-2685.
Read now
Alexandrosz Czira, Sneha Purushotham, Ike Iheanacho, Kieran J Rothnie, Chris Compton & Afisi S Ismaila. (2023) Burden of Disease in Patients with Mild or Mild-to-Moderate Chronic Obstructive Pulmonary Disease (Global Initiative for Chronic Obstructive Lung Disease Group A or B): A Systematic Literature Review. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 719-731.
Read now
Kieran J Rothnie, Sandra Joksaite, Leah B Sansbury, Chris Compton, Valentina Di Boscio & Afisi S Ismaila. (2022) Characteristics of New Users of Single- and Multiple-Inhaler Triple Therapy for COPD in Primary Care in England. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1455-1466.
Read now

Articles from other publishers (4)

Yanan Cui, Yiming Ma, Zhongshang Dai, Yingjiao Long & Yan Chen. (2023) Does the 2017 global initiative for chronic obstructive lung disease revision really improve the assessment of Chinese chronic obstructive pulmonary disease patients? A multicenter prospective study for more than 5 years. Chinese Medical Journal Publish Ahead of Print.
Crossref
Megan R Chalupsky, Krystal M Craddock, Michael Schivo & Brooks T Kuhn. (2023) Remote Patient Monitoring in the Management of Chronic Obstructive Pulmonary Disease. Journal of Investigative Medicine 70:8, pages 1681-1689.
Crossref
Yu-Ping Chang, Yu-Mu Chen, Ya-Chun Chang, Shih-Feng Liu, Wen-Feng Fang, Tung-Ying Chao, Chao-Chien Wu, Huang-Chih Chang, Meng-Chih Lin & Yung-Che Chen. (2022) Association of baseline parameters with year 0 and year 1 acute exacerbations in male patients with chronic obstructive pulmonary disease. International Journal of Immunopathology and Pharmacology 36, pages 039463202210990.
Crossref
Jun Watanabe, Kazuhiko Kotani & Alejandro Gugliucci. (2021) Paraoxonase 1 and Chronic Obstructive Pulmonary Disease: A Meta-Analysis. Antioxidants 10:12, pages 1891.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.